Mental Health & Substance Abuse Clinics in the US - Market Research Report (2014-2029)

Seeking help: Persistent provider shortages will impede clinics' capacity to treat patients

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Rising awareness of the economic, personal and societal benefits of mental health and substance abuse treatment has supported the development of mental health and substance abuse clinics. Expansion of mental health clinics has been vital, as rising rates of mental illness and a worsening opioid epidemic increase the need for comprehensive treatment. COVID-19 accelerated the extent of the mental health crisis in the US. The pandemic magnified the unmet need for mental health treatment, where an overburdened industry and labor shortages strained clinics. Despite this, rising incomes and insurance coverage in recent years have facilitated treatment access. Although cost barriers continue to impede care, revenue has expanded at a CAGR of 3.4% to $33.1 billion over the past five years. Revenue growth will be more subdued in 2023, increasing only 0.9% as recessionary concerns and a higher cost-of-living limit spending on healthcare services.

This industry includes establishments with medical staff that primarily provide outpatient services related to the diagnosis and treatment of substance abuse and other mental health disorders. The industry excludes facilities or hospitals that treat inpatients. It also excludes establishments that primarily use medical treatment to care for mental health patients.